Bempedoic acid/Ezetimibe Prescribing at MAPLE ACCESS PARTNERSHIP LLP
Lipid-regulating drugs | Cardiovascular System
Items (12m)
276
Total Quantity
4,946
NHS Cost
£9.3K
vs National Avg
+352%
MAPLE ACCESS PARTNERSHIP LLP prescribed 276 items of Bempedoic acid/Ezetimibe over the last 12 months at a cost of £9,321 to the NHS. This is 352% above the national average prescribing rate. Bempedoic acid/Ezetimibe is classified under Lipid-regulating drugs in the BNF.
Monthly Prescribing Trend
Jun 2026
16
Jun 2026
12
Jun 2026
11
Jun 2026
18
Jun 2026
16
Jun 2026
28
Jun 2026
30
Jun 2026
25
Jun 2026
31
Jun 2026
30
Jun 2026
33
Jun 2026
26
Prescribing Details
| Total Items | 276 |
|---|---|
| Total Quantity | 4,946 |
| Total NHS Cost | £9,321 |
| Presentations | 2 different forms |
| vs National Average | +352% |
Bempedoic acid/Ezetimibe Prescribing Comparison
| This practice | 276 items |
|---|---|
| National average per practice | 61 items |
| Difference | +352% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.